- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00951860
Assessment of Autonomic Maturation in Neonatal Period and Early Neural Development From a Longitudinal Prospective Cohort (AUBE)
Assessment of Autonomic Maturation in Neonatal Period and Early Neural Development From a Longitudinal Prospective Cohort : the AuBE Study
The heart rate variability assessment of the sympathetic-parasympathetic balance is a strong analytical tool in the autonomic nervous system (ANS) physiology, at each end of life.
In neonatology, it represents an important marker for understanding the breath and cardiac dysfunction, incriminated in the pathophysiology of unexplained death syndrome and apnea-bradycardia of prematurity.
If recent clinical studies conducted by our team highlight a close link between the maturation degree of the ANS and gestational or postnatal age, with a substantial autonomic dysfunction in preterm infants, no study to date has focused profile autonomic maturation in the first two years of life, as that period for the infant is a vulnerability "window" especially cardiopulmonary and neurological.
Psychomotor prognosis of newborns is more serious if prematurity is important and if periventricular leukomalacia or cortical anatomical brain lesions are obvious. However, the conventional imaging (Trans fontanel ultrasound, CT, MRI) is not sufficient in the neonatal period to thoroughly evaluate the neurological risk situations. During the neonatal period, the assessment of autonomic control, in practice easily quantifiable from time and frequency-domain analysis of cardiac RR variability, could be a strong marker, at a given time, from a neurological disorder undetectable by imaging, including sympathetic and parasympathetic nerve conduction dysfunction in some brainstem nuclei and cortical areas.
The postnatal profile of the autonomic balance, as a marker of well ANS regulation could become an additional support to correlate transient or permanent autonomic deficit with a psychomotor development disorder at 2 years of age or later. This tool could be a help to target the children with a neurological risk and to schedule early therapeutic interventions and psychological or educational support.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
To meet this objective, we propose to describe for the first time in a cohort of newborns, the cardiac autonomic maturation profile in the first two years of life and the neurological evolution at 2 years.
Main objective.
- Describe the pattern, i.e. the cardiac autonomic maturation during the first two years of life in a cohort of newborns.
Secondary objectives.
- Correlate in this cohort, the autonomous status at birth to the neurological psychomotor status at 2 years.
- Describe the autonomic pattern (evolution profile) during the first two years of life.
- According to specific criteria of pregnancy (maternal smoking, maternal hypertension and gestational age)
- According to data of morphometry (stature and weight development) at birth.
- According to the neonatal morbidity criteria: - bronchopulmonary dysplasia i.e. oxygen dependence at 36 weeks postnatal age, persistent ductus arterious, intra ventricular haemorrhage according to the Papille classification, periventricular leukomalacia, enterocolitis, nosocomial sepsis.
- According to the incidence of serious faintness and rhythmic disorders the two first years of life.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Saint-etienne, France, 42055
- CHU de Saint-Etienne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Every child born in the CHU of Saint-Étienne (inborn), any term of its birth, in the hospital neonatal unit at the time of registration (after 37 weeks corrected for prematurity) or in the maternity
- Written consent signed by parents
- Parents affiliated in a Social Security regimen
Exclusion Criteria:
- History of intrafamilial dysautonomia
- Heart malformation, congenital abnormality of the brainstem
- Permanent troubles of heart rate
- Any therapy at the time of the study or made in the weeks preceding the study, referred to cardiac or respiratory or known to alter the activity of the ANS
- General anesthesia within 2 weeks prior to registration
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Newborn
Every child born in the CHU of Saint-Étienne (inborn), any term of its birth, in the hospital neonatal unit at the time of registration (after 37 weeks corrected for prematurity) or in the maternity
|
Autonomic activity measured at birth and at 6, 12, 18 and 24 months is represented by time-domain indices (SDNN index, SDANN, pNN50) and frequency- domain indices(PTOT, VLF, LF, HF, ratio LF / HF, LFnu, HFnu), which reflect the short-term variability (parasympathetic branch) and medium term (ortho and parasympathetic branch) of the vegetative balance.
This subtle technical assessment of autonomic functioning has been validated in the literature for two decades
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Autonomic activity is represented by time-domain indices and frequency- domain indices, which reflect the short-term variability (parasympathetic branch) and medium term (ortho and parasympathetic branch) of the vegetative balance.
Time Frame: at birth and at 6, 12, 18 and 24 months
|
at birth and at 6, 12, 18 and 24 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the Bayley Scales of Infant Development, developmental with 4 areas of evaluation (motor or postural, oculomotor coordination, language, social relations) to calculate the global and partial quotient Development (QD).
Time Frame: At 24 months
|
At 24 months
|
Specific criteria of pregnancy
Time Frame: at birth
|
at birth
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Hugues PATURAL, MD PhD, CHU de Saint-Etienne
Publications and helpful links
General Publications
- Patural H, Teyssier G, Pichot V, Barthelemy JC. [Normal and changed heart rate maturation of the neonate]. Arch Pediatr. 2008 Jun;15(5):614-6. doi: 10.1016/S0929-693X(08)71851-7. No abstract available. French.
- Patural H, Pichot V, Jaziri F, Teyssier G, Gaspoz JM, Roche F, Barthelemy JC. Autonomic cardiac control of very preterm newborns: a prolonged dysfunction. Early Hum Dev. 2008 Oct;84(10):681-7. doi: 10.1016/j.earlhumdev.2008.04.010. Epub 2008 Jun 16.
- De Rogalski Landrot I, Roche F, Pichot V, Teyssier G, Gaspoz JM, Barthelemy JC, Patural H. Autonomic nervous system activity in premature and full-term infants from theoretical term to 7 years. Auton Neurosci. 2007 Oct 30;136(1-2):105-9. doi: 10.1016/j.autneu.2007.04.008. Epub 2007 Jun 7.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0908020
- 2009-A00325-52 (Other Identifier: AFSSAPS)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prematurity
-
Stanford UniversityMedtronic - MITGCompletedIntraventricular Hemorrhage of Prematurity | Complications of PrematurityUnited States
-
Universidade Federal do MaranhãoConselho Nacional de Desenvolvimento Científico e TecnológicoUnknown
-
University of WashingtonNational Institute of Neurological Disorders and Stroke (NINDS)CompletedExtreme PrematurityUnited States
-
University of Alabama at BirminghamRecruitingPrematurity; ExtremeUnited States
-
Stockholm UniversityKarolinska Institutet; Region Stockholm; Centrum för kompetensutveckling inom... and other collaboratorsActive, not recruiting
-
Guilherme Sant'Anna, MDCompleted
-
University of Kansas Medical CenterCompletedComplication of PrematurityUnited States
-
Zekai Tahir Burak Women's Health Research and Education...UnknownPrematurity of FetusTurkey
-
Mansoura University Children HospitalCompletedPrematurity, Mechanical VentilationEgypt
Clinical Trials on Autonomic Nervous System activity
-
Centre Hospitalier Universitaire de Saint EtienneCompletedCancer | Sequels | Complications | Autonomic Nervous SystemFrance
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
University of Sao PauloCompleted
-
Cambridge University Hospitals NHS Foundation TrustUnknownPregnancy Related | Inappropriate Sinus TachycardiaUnited Kingdom
-
University of TorontoRecruitingSarcopenia | Aging | Sedentary Behavior | Amino Acids | Dietary ProteinCanada
-
University of California, San FranciscoCompleted
-
University of PittsburghRecruiting
-
Stanley SkinnerUnknownIntervertebral Disc Displacement | Spinal Curvatures | Intervertebral Disc Degeneration | Spondylitis | Spinal Stenosis | Spondylosis | Spinal Neoplasms | Osteoarthropathy, Primary Hypertrophic
-
University of TorontoRecruitingPhysical Inactivity | Resistance Exercise | Amino Acids | Dietary ProteinCanada
-
Centre Hospitalier Universitaire, AmiensActive, not recruitingPreterm Infant | Exposure to RadiofrequencyFrance